Tizabate Tablet

About Tizabate 160 mg Tablet

Tizabate is a tablet containing fenofibrate 160 mg, a fibrate medicine used to treat high lipid levels in the blood when diet and other measures have not worked.

There are 9 brands of Fenofibrate listed in Bangladesh. The lowest listed price is Fenobate 200 mg Capsule at ৳ 7.00 per unit.

What is Tizabate 160 mg Tablet?

Tizabate 160 mg is a tablet made by Advanced Chemical Industries PLC. It contains fenofibrate, which belongs to the fibrate group of medicines. It is used for certain types of hyperlipidemia (high levels of fats in the blood) in patients who have not responded adequately to diet and other appropriate measures. Fenofibrate works by reducing total cholesterol, LDL cholesterol, triglycerides, and certain apolipoproteins, while increasing HDL cholesterol and apolipoproteins. It also lowers serum uric acid levels. The doctor decides the dose and course of treatment.

Uses of Tizabate

Tizabate is used to treat hyperlipidemias of type IIa, IIb, III, IV, and V in patients who have not responded adequately to diet and other appropriate measures. It helps lower total cholesterol, LDL cholesterol, triglycerides, and apolipoprotein B, and increases HDL cholesterol and apolipoproteins. It may also reduce serum uric acid levels. The doctor will determine if this medicine is suitable for you.

How to use Tizabate

Take Tizabate exactly as your doctor prescribes. The tablet should be taken with a meal to help the body absorb the medicine better. The dose and duration of treatment are decided by your doctor based on your condition and response. Do not change the dose or stop taking it without consulting your doctor. If you miss a dose, ask your doctor or pharmacist for advice.

Side effects of Tizabate

Like all medicines, Tizabate can cause side effects, although not everyone gets them. Common side effects include gastrointestinal symptoms such as nausea, loss of appetite, and stomach pain. Other possible effects are itching, hives, impotence, headache, dizziness, vertigo, fatigue, and hair loss. Muscle toxicity has also been reported. If you experience any side effects, tell your doctor or pharmacist.

Safety and precautions

Tizabate is not recommended for pregnant women and is contraindicated during breastfeeding. It should not be used in people with severe kidney or liver problems, existing gallbladder disease, or a history of photosensitivity to ketoprofen. Special care is needed in patients with kidney disease, as increases in serum creatinine may lead to muscle toxicity. Liver function tests are recommended every three months during the first year. Tell your doctor about all your medical conditions and medicines before starting Tizabate.

Frequently asked questions

What is Tizabate used for and what kind of medicine is it?

Tizabate is a fibrate medicine used to treat certain types of high lipid levels (hyperlipidemias) in patients who have not responded adequately to diet and other measures. It contains fenofibrate and helps lower cholesterol and triglycerides while increasing HDL cholesterol.

What medicines may interact with Tizabate?

Tizabate may interact with blood thinners like warfarin (increasing bleeding risk), antidiabetic drugs (additive effect on glucose tolerance), cyclosporine (increased kidney toxicity), and statins (increased risk of muscle breakdown). Always inform your doctor about all medicines you take.

What does the dosage form and strength mean?

Tizabate is a tablet, a solid dosage form to be swallowed. The strength is 160 mg, meaning each tablet contains 160 milligrams of fenofibrate. Your doctor will decide the appropriate dose and course for you.

Who should not take Tizabate?

Tizabate is not for people allergic to fenofibrate, those with severe kidney or liver impairment, gallbladder disease, breastfeeding mothers, or those with photosensitivity to ketoprofen. Pregnant women should not take it. Consult your doctor if you have any of these conditions.

Also available as

200 mg (Capsule)

Indications

Fenofibrate is indicated for hyperlipidemias of type lla, llb, III, IV & V in patients who have not responded adequately to diet & other appropriate measures.

Pharmacology

Fenofibrate is a fibric acid derivative. Fenofibrate is rapidly hydrolyzed after oral ingestion to its pharmacologically active form, fenofibric acid. Fenofibric acid produces reductions in total cholesterol, LDL cholesterol, Apo-lipoprotein B, Total triglycerides and VLDL. In addition, treatment with Fenofibrate results in increases in HDL and apo-proteins apoAI apoAII. Fenofibrate also reduces serum uric acid levels in hyperuricemic and normal individuals by increasing the urinary excretion of uric acid. The micronised form of Nofiate (Fenofibrate) has enhanced absorption over the non-micronised formulation.

Dosage & Administration

  • For the treatment of adult patients with hypercholesterolemia or mixed hyperlipidemia, the initial dose of Fenofibrate is 200 mg per day.
  • For adult patients with hypertriglyceridemia, the initial dose is 67 to 200 mg per day.
  • Dose should be individualized according to patient response. Fenofibrate should be given with meal there by, optimizing the bioavailability of the medication. Or, as directed by the registered physician.

Interaction

Fenofibrate has been reported to potentiate the anticoagulant effects of warfarin. When administered with antidiabetic drug it may improve glucose tolerance and have additive effect. Fenofibrate may also increase the nephrotoxicity of cyclosporine. Due to a potential increase in the risk of rhabdomyolysis, cautions should be taken against the use of Fenofibrate with HMG-CoA reductase inhibitors. However, the use of low-dose statins with Fenofibrate appears to be well tolerated.

Contraindications

Fenofibrate is contraindicated in patients with hypersensitivity to Fenofibrate, severe renal or hepatic impairment, existing gall bladder disease, breast feeding mothers, photosensitivity to ketoprofen.

Side Effects

Gastro-intestinal (e.g. nausea, anorexia, gastric pain), pruritus, urticaria, impotence, also headache, dizziness, vertigo, fatigue, hair loss; myotoxicity.

Pregnancy & Lactation

Fenofibrate is not recommended for pregnant women.

Precautions & Warnings

Special care needed in patients with renal disease, as progressive increases in serum creatinine concentration or failure to follow dosage guidelines may result in myotoxicity; discontinue if myotoxicity suspected or creatinine kinase concentration increases significantly. Liver function tests recommended every 3 months for first year.

Overdose Effects

There is no specific treatment for overdose with Fenofibrate. General supportive care of the patients is indicated, including monitoring of vital signs and observation of clinical status, should an overdose occur. Because Fenofibrate is highly bound to plasma proteins, hemodialysis should not be considered.

Storage Conditions

Do not store above 30°C. Keep away from light and out of the reach of children.

Alternative brands of Fenofibrate

Other brands with the same generic name, cheapest first.

Nofiate Capsule

200 mg

Fenofibrate

Incepta Pharmaceuticals Ltd.

৳ 6.86 ৳ 7.00 2% off per unit

Lipidof Capsule

200 mg

Fenofibrate

The ACME Laboratories Ltd.

৳ 6.9 ৳ 7.04 2% off per unit

Lipired Capsule

200 mg

Fenofibrate

Square Pharmaceuticals PLC.

৳ 6.9 ৳ 7.04 2% off per unit

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.